Results 201 to 210 of about 332,088 (306)

Observational Management for Patients with Biochemical Recurrence Following Radical Prostatectomy, in the Absence of Detectable Disease on Restaging PSMA PET/CT Imaging. [PDF]

Diagnostics (Basel)
de Bie KCC, Mellema JJ, Meijer D, Teunissen FR, van Leeuwen PJ, Oprea-Lager DE, Donswijk ML, van den Bergh RCN, Vis AN.   +8 more
europepmc   +1 more source

Impact of European Association of Urology Combination and Platinum Eligibility on Real‐World Treatment Sequences and Survival in Japanese Patients With Metastatic Urothelial Carcinoma

International Journal of Urology, Volume 33, Issue 5, May 2026.
ABSTRACT Objectives To evaluate the prevalence of European Association of Urology‐defined combination and platinum eligibility at first‐line treatment initiation, and to assess their impact on conventional treatment sequence and overall survival in a real‐world Japanese cohort. Methods We retrospectively analyzed 148 patients with metastatic urothelial
Takashi Kawahara, Yoshiyuki Nagumo, Kozaburo Tanuma, Kazuki Hamada, Akane Yamaguchi, Satoshi Nitta, Masanobu Shiga, Atsushi Ikeda, Akio Hoshi, Shuya Kandori, Hiroyuki Nishiyama   +10 more
wiley   +1 more source

Therapeutic Effect of Baicalin-Loaded Thermosensitive Liposomal Hydrogel in Autoimmune Uveitis. [PDF]

ACS Omega
Zhu L, Li N, Zhang R, Shao Y, Lai J.
europepmc   +1 more source

Gleason Regrading After Prostatectomy—Results From the Irish Prostate Cancer Outcome Research (IPCOR) Situated in the International Context

International Journal of Urology, Volume 33, Issue 5, May 2026.
ABSTRACT Background Accurate Gleason grading is crucial for prostate cancer (PCa) treatment decisions; incorrect assessment can lead to under‐ or overtreatment; discordance between biopsy and radical prostatectomy (RP) grades is a marker of this inaccuracy.
Noa Gordon, Ayush Amish Patel, Wasfa Farooq, William Watson, David Galvin   +4 more
wiley   +1 more source

Time to BCR and cancer-specific mortality after radiotherapy or prostatectomy: implications for risk stratification and follow-up. [PDF]

World J Urol
Pellegrino F, Grauer R, Falagario UG, Akre O, Aly M, Nordström T, Grönberg H, Egevad L, Tewari A, Ferro M, Gandaglia G, Briganti A, Montorsi F, Lantz A, Wiklund PN.   +14 more
europepmc   +1 more source

Les eaux et forêts en Bourgogne ducale (vers 1350-vers 1480). Société et biodiversité

Bulletin du Centre d’Études Médiévales d’Auxerre, 2009
Corinne Beck
doaj   +1 more source

Oncological Outcomes of Epirubicin-based Hyperthermic Intravesical Chemotherapy in Bacillus Calmette-Guérin (BCG)-naïve Patients and Patients with BCG Failure: A Multicenter Retrospective Observational Study. [PDF]

Eur Urol Open Sci
Arnold N, Koneval L, Blanc J, Lucca I, Vartolomei MD, Schneidewind L, Giudici N, Thalmann GN, Kiss B, Roth B.   +9 more
europepmc   +1 more source

Optimizing inpatient access to oral contraceptives: A quality improvement approach in behavioral health. [PDF]

Explor Res Clin Soc Pharm
Pierce RS, Crews DN, Pierce BJ, Wulffson CK.   +3 more
europepmc   +1 more source

BRD3 PROTAC degrader targets H3K18ac to alleviate retinal microglia-driven uveitis. [PDF]

iScience
Zhang Z, Lan T, Liu Y, Yang H, Shu N, Li R, Li W, Zhou Q, Yang P, Rao Y, Hou S.   +10 more
europepmc   +1 more source

Network pharmacology and molecular docking analyses of the Wuwei Mingmu formula indicate that IL-10 and IL-6 are critical targets against experimental autoimmune uveitis in rats. [PDF]

Front Pharmacol
Liang X, Zhang J, Yuan F, Liang L, Li J, Duan Y.   +5 more
europepmc   +1 more source